Sunitinib versus interferon-alfa (IFN-α) as first-line treatment of metastatic renal cell carcinoma (mRCC): Updated results and analysis of prognostic factors Meeting Abstract
| Authors: | Motzer, R. J.; Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixe, O.; Bjarnason, G. A.; Kim, S. T.; Chen, I.; Michaelson, D. |
| Abstract Title: | Sunitinib versus interferon-alfa (IFN-α) as first-line treatment of metastatic renal cell carcinoma (mRCC): Updated results and analysis of prognostic factors |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 241s |
| Language: | English |
| ACCESSION: | WOS:000455043701155 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.5024 |
| Notes: | Meeting Abstract: 5024 -- Source: Wos |
